Changes in fast antiplasmin (alpha-2-antiplasmin) activity of the plasma of thoracotomized patients
Fridrich, L.; Tuchmann, A.; Endler, T.; Meryn, S.; Moritz, E.
Praxis und Klinik der Pneumologie 37 Suppl. 1: 742-744
1983
ISSN/ISBN: 0342-7498 PMID: 6647325 Document Number: 197708
Document emailed within 1 workday
Related Documents
Musatov, M.I.; Zhabin, S.G.; Konenkov, V.I.; Zorin, N.A. 1994: The effect of plasmin and its complexes with alpha 2-macroglobulin and alpha 2-antiplasmin on the proliferative activity of human lymphocytes Biulleten' Eksperimental'noi Biologii i Meditsiny 118(9): 304-305Gonias, S.L.; Fuchs, H.E.; Pizzo, S.V. 1982: A unique pathway for the plasma elimination of alpha 2-antiplasmin-protease complexes in mice Thrombosis and Haemostasis 48(2): 208-210
Dabrowska, M.; Kemona, H.; Prokopowicz, J.; Kretowska, J.; Kiluk, S. 1991: Serum antithrombin IIi and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy Neoplasma 38(3): 249-252
Tomczykowska, M.łg.; Bielak, J.; Bodys, A. 2003: Evaluation of platelet activation, plasma antithrombin IIi and alpha2-antiplasmin activities in hypertensive patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 58(1): 15-20
Kluft, C.; Wijngaards, G.; van Voorthuizen, H. 1984: Revised reference curve for the alpha 2-antiplasmin assay by the addition of detergents Thrombosis and Haemostasis 51(2): 297
Knot, E.A.; ten Cate, J.W.; Lamping, R.J.; Gie, L.K. 1986: Alpha 2-antiplasmin: functional characterization and metabolism in a heterozygote deficient patient Thrombosis and Haemostasis 55(3): 375-378
Matsuo, O.; Mihara, H. 1977: In vitro and in vivo measurement of total antiplasmin activity Thrombosis and Haemostasis 37(2): 216-221
Du, X.H.; Glas-Greenwalt, P.; Kant, K.S.; Allen, C.M.; Hayes, S.; Pollak, V.E. 1985: Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin) Clinical Nephrology 24(4): 186-191
Kotschy, M.; Drewniak, W.; Graczykowska-Koczorowska, A.; Listopadzki, D. 1992: Antithrombin IIi and alpha-2-antiplasmin activities compared with other hemostasis parameters in uncomplicated diabetes mellitus, type 2 Polski Tygodnik Lekarski 47(1-2): 17-18
Zabelin, N.N.; Gribauskas, P.S.; Moĭseenok, A.G. 1988: Ultrasonic coagulometry as a method of testing compounds with antiplasmin activity Biofizika 33(2): 226-228
Baele, G.; Kaufman, J.M.; Thiery, M.; Vermeulen, A.; Barbier, F. 1981: Plasminogen, fibrinogen, alpha 2-antiplasmin and antithrombin-III levels during a single cycle of a combined oral contraceptive regime Acta Clinica Belgica 36(6): 280-285
Levin, G.I. 1975: Thromboelastographic method of determination of plasminogen proactivator, antiactivator, and antiplasmin activity Laboratornoe Delo 11: 650-651
Jovicić, A.; Mijusković, Z.; Magdić, B. 1983: Antiplasmin in patients with cerebral infarct Vojnosanitetski Pregled 40(2): 104-106
Reed, G.L.; Matsueda, G.R.; Haber, E.; Haber, E. 1992: Platelet factor XIIi increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin Thrombosis and Haemostasis 68(3): 315-320
Wolk, L.A.; Wilson, R.F.; Burdick, M.; Selik, N.; Brown, J.; Starricco, A.; Mammen, E.F. 1985: Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass American Surgeon 51(6): 309-313
Schröder, V.; Kohler, H.P. 2000: Effect of factor XIIi Val34Leu on alpha2-antiplasmin incorporation into fibrin Thrombosis and Haemostasis 84(6): 1128-1130
Miyatani, K.; Fukui, I. 1971: Ultra-micro-determination of plasmin using a fibrin plate. 3. Relationship to antiplasmin agents Rinsho Byori. Japanese Journal of Clinical Pathology 19(12): 859-862
Grabarczyk, E.; Wodyńska, T.; Kotschy, M. 2004: Fibrinolysis parameters: plasmin-alpha2 antiplasmin complexes (PAP) and D-dimers in acute coronary syndromes without ST segment elevation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(102): 555-557
Abe, K.; Endo, E.; Khato, J. 1977: The development of DIC in tumor (AH-109A) inoculated rats with priorly observed plasmin-antiplasmin changes and probable hypercoagulable states Rinsho Byori. Japanese Journal of Clinical Pathology 25(10): 781-786
Roche, M.; Pattabiraman, T.N. 1992: Further studies on proteinases and alpha 2-macroglobulin activity in diabetic plasma Indian Journal of Biochemistry and Biophysics 29(2): 189-191